المؤلفون: Aviva Tugendhaft, Nicola Christofides, Nicholas Stacey, Kathleen Kahn, Agnes Erzse, Marion Danis, Marthe Gold, Karen Hofman

المصدر: Health Expectations, Vol 27, Iss 1, Pp n/a-n/a (2024)

مصطلحات موضوعية: priority‐setting, public engagement, rural health, social inclusion, South Africa, Medicine (General), R5-920, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1369-6513Test; https://doaj.org/toc/1369-7625Test

الوصول الحر: https://doaj.org/article/779ae773fa044fb7bd83efc3b3619d5eTest

المؤلفون: Aviva Tugendhaft, Marion Danis, Nicola Christofides, Kathleen Kahn, Agnes Erzse, Marthe Gold, Rhian Twine, Audrey Khosa, Karen Hofman

المصدر: International Journal of Health Policy and Management, Vol 11, Iss 2, Pp 197-209 (2022)

مصطلحات موضوعية: priority setting, public engagement, rural health, south africa, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://www.ijhpm.com/article_3852_e58ad36a34a3ebf12a15b17e824dd18a.pdfTest; https://doaj.org/toc/2322-5939Test

الوصول الحر: https://doaj.org/article/65298fdfacd74dce9d64adc4a90d4da2Test

المؤلفون: Kathleen Kahn, Rhian Twine, Karen Hofman, Marion Danis, Aviva Tugendhaft, Nicola Christofides, Marthe Gold, Agnes Erzse

المصدر: BMJ Global Health, Vol 7, Iss Suppl 2 (2022)

مصطلحات موضوعية: Medicine (General), R5-920, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2059-7908Test

الوصول الحر: https://doaj.org/article/4ad80d75a6da4c828296377ef0232388Test

المؤلفون: Michael Drummond, Diana Brixner, Marthe Gold, Paul Kind, Alistair Mcguire, Erik Nord, I. A. Vilum, D. Yu. Belousov

المصدر: Качественная клиническая практика, Vol 0, Iss 2, Pp 98-103 (2018)

مصطلحات موضوعية: распределение ресурсов, качество жизни, оценка состояния здоровья, resource allocation, quality of life, health state valuation, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://www.clinvest.ru/jour/article/view/20Test; https://doaj.org/toc/2588-0519Test; https://doaj.org/toc/2618-8473Test

الوصول الحر: https://doaj.org/article/73c97978c8e54440bdb57464eb3a0022Test

المؤلفون: Joseph Lipscomb, Michael Drummond, Dennis Fryback, Marthe Gold, Dennis Revick, I. A. Vilum, S. L. Plavinskii, D. Yu. Belousov

المصدر: Качественная клиническая практика, Vol 0, Iss 2, Pp 79-91 (2018)

مصطلحات موضوعية: quality-adjusted life years, health-related quality of life, cost-utility analysis, outcome assessment, health status, годы жизни, откорректированные на качество, связанное со здоровьем качество жизни, анализ цена-польза, оценка исходов, статус здоровья, qaly, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://www.clinvest.ru/jour/article/view/18Test; https://doaj.org/toc/2588-0519Test; https://doaj.org/toc/2618-8473Test

الوصول الحر: https://doaj.org/article/b4876e80e47443978388ec05911ee782Test

المؤلفون: Brayan V. Seixas, Craig Mitton, Marion Danis, Iestyn Williams, Marthe Gold, Rob Baltussen

المصدر: International Journal of Health Policy and Management, Vol 6, Iss 12, Pp 733-734 (2017)

مصطلحات موضوعية: Participation, Legitimacy Stakeholder, Priority Setting, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: http://www.ijhpm.com/article_3390_f7198e4f4157aff28db3c49b2b4cb28a.pdfTest; https://doaj.org/toc/2322-5939Test

الوصول الحر: https://doaj.org/article/757ccd89069f46929ddfc03b0237d2bcTest

المؤلفون: Rob Baltussen, Craig Mitton, Marion Danis, Iestyn Williams, Marthe Gold

المصدر: International Journal of Health Policy and Management, Vol 6, Iss 3, Pp 127-128 (2017)

مصطلحات موضوعية: Priority Setting, Legitimacy, Stakeholder Participation, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: http://www.ijhpm.com/article_3316_8ed196cdfc322be73c81139cb7d529e3.pdfTest; https://doaj.org/toc/2322-5939Test

الوصول الحر: https://doaj.org/article/6270ef3d8a5c40679d917beb1fd68bacTest

المؤلفون: Joseph Lipscomb, Michael Drummond, Dennis Fryback, Marthe Gold, Dennis Revick, I. Vilum A., S. Plavinskii L., D. Belousov Yu., Dennis Revicki, И. Вилюм А., С. Плавинский Л., Д. Белоусов Ю.

المصدر: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 2 (2015); 79-91 ; Качественная Клиническая Практика; № 2 (2015); 79-91 ; 2618-8473 ; 2588-0519

مصطلحات موضوعية: quality-adjusted life years, health-related quality of life, cost-utility analysis, outcome assessment, health status, годы жизни, откорректированные на качество, связанное со здоровьем качество жизни, анализ цена-польза, оценка исходов, статус здоровья, QALY

وصف الملف: application/pdf

العلاقة: https://www.clinvest.ru/jour/article/view/18/18Test; Drummond M., Sculpher T.G., O’Brien B.S. Methods for the Economic Evaluation of Health Care Programmes (3rd ed.). New York: Oxford University Press, 2005.; Gold M., Siegel R., Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.; National Institute for Health and Clinical Excellence (NICE). Available from: http://www.nice.org.ukTest [Accessed January 24, 2009].; O’Donnell J., Pham S., Pashos C., Miller D. Health technology assessment: Lessons learned from around the world. Value Health 2009;12(Suppl.) в печати.; ISPOR. ISPOR Thirteenth Annual International Meeting Abstracts. Value Health 2008;3:A1-311.; Statistics Canada. Canadian Community Health Survey. September 2000 and Ongoing. Available from: http://www.statcan.gc.caTest [Accessed January 24, 2009].; Fryback D.G., Dunham N.C., Palta M., et al. Norms for six generic health-related quality-of-life indexes from the national health measurement study. Med Care 2007;45:1162-70.; Fryback D.G., Lawrence W.F., Martin P.A., et al. Predicting quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997;17:1-9.; Feeny D., Furlong W., Torrance G.W., et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 System. Med Care 2002;40:113-28; Brooks R., Rabin R., de Charro F The Measurement and Valuation of Health Status Using EQ-5D: a European Perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2003.; Andresen E.M., Rothenberg B.M., Kaplan R.M. Performance of a self-administered mail version of the Quality of Well-Being (QWB-SA) Questionnaire among older adults. Med Care 1998; 36:1349-60.; Brazier J.E., Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851-9.; Erickson P. Evaluation of a population-based measure of quality of life: the Health and Activity Limitations Index (HALex). Qual Life Res 1998;7:101-14.; Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy years equivalents. Med Decis Making 1989;9:142-9.; Nord E. Cost-Value Analysis in Health Care: Making Sense out of QALYs. New York: Oxford University Press, 1999.; Ubel P., Nord E., Gold M., et al. Improving value measurement in cost-effectiveness analysis. Med Care 2000;38:892-901.; Dolan P., Kahneman D. Interpretations of utility and their implications for the valuation of health. Econ J 2008;118:215-34.; Hausman D.M. Valuing health properly. Health Econ Policy Law 2008;3:79-83.; Miller W., Robinson L.A., Lawrence R.S., eds. Valuing Health for Regulatory Cost-Effectiveness Analysis. Washington DC: Institute of Medicine, National Academy Press, 2006.; Neumann P.J. Using Cost-Effectiveness Analysis to Improve Health Care. New York: Oxford University Press, 2005.; US Food and Drug Administration. Guidance for industry- patient-reported outcome measures: use in medical product development to support labeling claims. 2006. Available from: http:// www.fda.gov/cber/gdlns/prolbl.pdf [Accessed January 24, 2009].; U.S. Federal Registry. Medicare program: criteria and procedures for extending coverage decisions that relate to health care technology. US Federal Register 1989;54:4302-18.; Feeny D. The roles of preference-based measures in support of cancer research and policy. In: Lipscomb J., Gotay C.C., Snyder C., eds. Outcomes Assessment in Cancer: Measures, Methods, Applications. Cambridge: Cambridge University Press, 2005.; Brauer C.A., Rosen A.B., Greenberg D., Neumann P.J. Trends in the measurement of health utilities in published cost-utility analyses. Value Health 2006; 9:213-8.; Szende A., Williams A., eds. Measuring Self-Reported Population Health: an International Perspective Based on the EQ-5D. Budapest: Spring Med Publishing, 2004.; Bryan S., Sofaer S., Siegelberg T., Gold M.R. Has the time come for CEA in U.S. Health Care? J Health Econ Policy Law in press.; US Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey (MEPS). Available from: http:// www.meps.ahrq.gov [Accessed January 24, 2009].; Sullivan P. W., Ghushchyan V. Mapping the EQ-5D Index from the SF-12: U.S. general population preferences in a nationally representative sample. Med Decis Making 2006;26:401-9.; Lawrence W.F., Fleishman J.A. Predicting EuroQol EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample. Med Decis Making 2004;24:160-9.; Franks P., Lubetkin E.I., Gold M.R., et al. Mapping the SF-12 to the EuroQol EQ-5D Index in a national U.S. sample. Med Decis Making 2004;24:247-54.; Statistics Canada and the US Centers for Disease Control and Prevention. Joint Canada-United States Survey of Health (JCUSH). Available from: http:// www.cdc.gov/nchs/about/major/ nhis/Canada_US.htm [Accessed January 24, 2009].; Statistics Canada. National Population Health Survey. Available at: http://www.statcan.gc.ca/bsolc/olc-cel/olc-cel?lang=engTest& catno=82-618-M [Accessed January 24, 2009].; US Centers for Medicare and Medicaid Services. Medicare Health Outcomes Survey. Available from: http://www.cms.hhs.gov/hosTest/ [Accessed January 24, 2009].; Kind P., Dolan P., Gudex C., Williams A. Variations in population health: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-41.; Shaw J.W., Johnson J.A., Coons S.J. U.S. Valuation of the EQ-5D Health States: development and testing of the D1 valuation model. Medical Care 2005; 43: 203-20.; Revicki D.A., Kawata A., Harnam N., et al. Predicting EuroQol (EQ-5D) scores from the Patient Reported Outcomes Measurement Information System (PROMIS) global items and domain item banks in a United States representative sample. UnitedBio-Source Corp. working Paper, November 2008.; Ware JE Jr. SF-36® Health Survey Update. Available from: http:// www.sf-36.org/tools/sf36.shtml [Accessed January 24, 2009].; Horsman J., Furlong W., Feeny D., Torrance G. The Health Utilities Index (HUI): concepts, measurement properties, and applications. Health Qual Life Outcomes 2003;1:54-66.; Maddigan S.L., Feeny D.H., Johnson J.A., for the DOVE Investigators. A comparison of the Health Utilities Indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making 2003;23:489- 501.; Pickard A., Kohlmann T., Janssen M., et al. Evaluating equivalency between response systems: application of the Rasch Model to 3-Level and 5-Level EQ-5D. Med Care 2007;45:812-9.; National Institutes of Health. Patient-reported outcomes measurement information system: dynamic tools to measure health outcomes from the patient perspective. Available from: http:// www.nihpromis.org [Accessed January 24, 2009].; Petrillo J., Cairns J. Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Exp Rev Pharmacoeconom Res 2008;8:453-6.; Franks P., Hanmer J., Fryback D.G. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consis-tency in cost-effectiveness analysis. Med Care 2006;44:478- 85.; Janssen M.F., Birnie E., Bonsel G.J. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a U.S. general population survey using Shannon’s indices. Qual Life Res 2007;16:895- 904.; Stevens K., McCabe C., Brazier J., Roberts J. Multi-attribute utility functions or statistical inference models: a comparison of health state valuation models using the HUI2 health state classification system. J Health Econ 2006;26:992-1002.; Fryback D., Palta M., Cherepanov D., et al. for the Health Measurement Research Group. Cross-walks among five self-reported summary health utility indexes: progress and prospects. Presented at the Annual Meeting of the Society for Medical Making, Pittsburgh, PA, Oct 24, 2007.; Scientific Advisory Committee for the Medical Outcomes Trust (Lohr K, et al.) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193- 205.; Lipscomb J., Snyder C.F., Gotay C. Cancer outcomes measurement through the lens of the medical outcomes trust framework. Qual Life Res 2007;16:143-64.; Salomon J.A., Murray C.J. A multi-method approach to measuring health-state valuations. Health Econ 2006;13:281-90.; Lipscomb J. Time preference for health in cost-effectiveness analysis. Med Care 1989;27:S233-53.; Nord E., Pinto J.L., Richardson J., et al. Societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999;8:25-39.; Bleichrodt H., Doctor J., Stolk E. A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J Health Econ 2005;24:655-78.; Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ 1991;10:21-41.; Johannesson M. Should we aggregate relative or absolute changes in QALYs? Health Econ 2001;10:573-7.; Epstein D.M., Chalabi Z., Claxton K., Sculpher M. Efficiency, equity, and budgetary priorities. Med Decis Making 2007;27: 128-37.; Stinnett A.A., Paltiel A.D. Mathematical programming for the efficient allocation of health care resources. J Health Econ 1996;15: 641-53; Chen M.M., Bush J.W. Maximizing health system output with political and administrative constraints using mathematical programming. Inquiry 1977;13:215-27.; NICE Citizens Council. NICE Citizens Council report: ultra orphan drugs. London, November 2004. Available from: http:// www.nice.org.uk/ [Accessed January 24, 2009]. [Alternatively or together, cite: Culyer AJ. NICE’s Use of Cost-Effectiveness as an Exemplar of a Deliberative Process. Health Econ Policy Law 2006;1:299-318. and/or a critique of the process.]. 59 Gold MR, Sofaer S, Siegelberg T. Medicare and cost-effectiveness analysis: time to ask the taxpayer. Health Aff (Millwood) 2007;26:1399-406; https://www.clinvest.ru/jour/article/view/18Test

الإتاحة: https://www.clinvest.ru/jour/article/view/18Test

المؤلفون: Michael Drummond, Diana Brixner, Marthe Gold, Paul Kind, Alistair Mcguire, Erik Nord, I. Vilum A., D. Belousov Yu., Alistair McGuire, И. Вилюм А., Д. Белоусов Ю.

المصدر: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 2 (2015); 98-103 ; Качественная Клиническая Практика; № 2 (2015); 98-103 ; 2618-8473 ; 2588-0519

مصطلحات موضوعية: распределение ресурсов, качество жизни, оценка состояния здоровья, resource allocation, quality of life, health state valuation

وصف الملف: application/pdf

العلاقة: https://www.clinvest.ru/jour/article/view/20/20Test; Nord E., Daniels N., Kamlet M. QALYs: some challenges. Value Health 2008;12(Suppl. 1):S10-5.; Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.; Fryback D.G., Palta M., Cherepov D., et al. Cross-walks among five self-reported summary health utility indexes: progress and prospects. Med Decis Making 2008;28:E24.; Rawlins M.D., Culyer A.J. National institute for clinical excellence and its value judgments. BMJ 2004;329:224-7.; Aspinall S.L., Good C.B., Glassman P.A., Valentino M.A. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veteran Affairs. Med Care 2005;43(Suppl. 7):S20-6.; Wu W.K., Sause R.B., Zacker C. Use of health-related quality of life information in managed care formulary decision-making. Res Social Adm Pharm 2005;1:579-98.; Gold M.R., Sofaer S., Siegelberg T. Medicare and CEA; time to ask the taxpayers. Health Aff (Millwood) -2007;5:1399-406.; Sofaer S., Bryan S., Gold M.R. Decision-makers’ attitudes toward cost-effectiveness analysis. Abstract. Academy Health, Orlando, July 5, 2007.; Neumann P.J., Palmer J.A., Daniels N., et al. Panel on integrating cost-effectiveness considerations into health policy decisions. Am J Manag Care 2008;14:185-8.; American College of Physicians. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;149:956- 61.; https://www.clinvest.ru/jour/article/view/20Test

الإتاحة: https://www.clinvest.ru/jour/article/view/20Test

المؤلفون: Aviva Tugendhaft, Karen Hofman, Marion Danis, Kathleen Kahn, Agnes Erzse, Rhian Twine, Marthe Gold, Nicola Christofides

المصدر: Abstracts.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bbdf35a70454b51b094be9be13540298Test
https://doi.org/10.1136/bmjgh-2022-isph.6Test